Xilio Development
Price & Volume
Stats
See more52W Range | $0.58-$1.70 |
Market Cap | $45.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $4.6M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $4.6M |
Diluted EPS | -$1.55 |
News
See moreYahoo Finance • 7 days ago
Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Yahoo Finance • 20 days ago
Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs
Yahoo Finance • 20 days ago
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Yahoo Finance • 28 days ago
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Rene Russo BCPS, Pharm.D. |
Address | 828 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 73 |
